Carisma Therapeutics, Inc. earnings per share and revenue

CARM earnings per share for the last quarter are -0.31 USD whereas the estimation was -0.32 USD which accounts for 1.59% surprise. Company revenue for the same period amounts to 3.38 M USD despite the estimated figure of 5.47 M USD. Estimated earnings per share for the next quarter are -0.17 USD, and revenue is expected to reach 5.46 M USD. Also watch annual changes over time to get a bigger picture of CARM earnings per share and revenue dynamics.